The pathophysiological processes in the later progressive phase of multiple sclerosis heavily implicate worsening astrocytopathology and resident microglia activation.31 Along those lines, only GFAP and none of the inflammatory proteins were able to predict DP over the 5-year follow-up period within our relatively older study population. This evidence concerns the gene GFAP and multiple sclerosis.